Physician profile
Daniel Mazzaferro
NPI 1871097758
$8,093.35
in general payments reported to CMS, 2019-2025
20 companies · $2,275 in 2025
The $2,275 reported for 2025 was more than what 86% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,657 · 2020: $608 · 2021: $493 · 2022: $1,895 · 2023: $609 · 2024: $556 · 2025: $2,275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,060 · Travel and Lodging: $1,379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,060.46 |
| Travel and Lodging | $1,378.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $2,134.12 | 2022-2025 | Avance Nerve Graft |
| Allergan, INC. | $1,526.53 | 2019-2022 | |
| Integra Lifesciences Corporation | $858.26 | 2020-2022 | |
| Tela Bio, INC. | $615.86 | 2021-2022 | |
| Sientra, INC. | $480.28 | 2022 | |
| Medical Device Business Services, INC. | $339.98 | 2020 | |
| Abbvie INC. | $316.91 | 2024-2025 | |
| Rti Surgical, INC | $316.83 | 2023-2024 | |
| Depuy Synthes Sales INC. | $169.81 | 2020-2022 | |
| Davol INC. | $154.83 | 2024 | |
| Mentor Worldwide LLC | $147.66 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Polynovo North America LLC | $141.42 | 2023 | |
| Smith+Nephew, INC. | $140.40 | 2022-2023 | Pico 7 |
| Aroa Biosurgery Incorporated | $132.24 | 2023 | |
| Celgene Corporation | $124.55 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $119.04 | 2020 | |
| Acera Surgical, INC. | $118.10 | 2019 | |
| Kci USA, INC. | $98.54 | 2021 | |
| Straumann USA LLC | $81.00 | 2025 | |
| Kerecis Limited | $76.99 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Mazzaferro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.